The development of cell based bioartificial kidney (BAK) could improve existing dialysis therapies for the removal of protein-bound toxins. A key requirement for the BAK is the formation of a “living membrane” consisting of a tight renal cells monolayer with preserved functional organic ion transporters, on an artificial porous membrane.The main aim of this thesis is to develop an upscaled BAK prototype, making use of conditionally immortalized human proximal tubule epithelial cells (ciPTEC), seeded on functionalized hollow fiber membranes (HFM). First, we develop an optimal coating on the external surface of a commercially available HFM module. CiPTEC are seeded and cultured under static conditions on the functionalized HFM. We prove that ...
Increasing incidence of renal pathology in the western world calls for innovative research for the d...
Novel renal replacement therapies, such as a bioartificial kidney (BAK), are needed to improve curre...
DMPK (Drug Metabolism and Pharmacokinetics) studies are essential for drug development but 90% of po...
The accumulation of protein-bound toxins in dialyzed patients is strongly associated with their high...
The limited removal of metabolic waste products in dialyzed kidney patients leads to high morbidity ...
The bioartificial kidney (BAK) aims at improving dialysis by developing 'living membranes' for cells...
The bioartificial kidney (BAK) aims at improving dialysis by developing 'living membranes' for cells...
Currently available treatment options for patients affected by chronic kidney disease (CKD) comprise...
Patients with end-stage kidney disease (ESKD) suffer from high levels of protein-bound uremic toxins...
Increasing incidence of renal pathology in the western world calls for innovative research for the d...
Novel renal replacement therapies, such as a bioartificial kidney (BAK), are needed to improve curre...
DMPK (Drug Metabolism and Pharmacokinetics) studies are essential for drug development but 90% of po...
The accumulation of protein-bound toxins in dialyzed patients is strongly associated with their high...
The limited removal of metabolic waste products in dialyzed kidney patients leads to high morbidity ...
The bioartificial kidney (BAK) aims at improving dialysis by developing 'living membranes' for cells...
The bioartificial kidney (BAK) aims at improving dialysis by developing 'living membranes' for cells...
Currently available treatment options for patients affected by chronic kidney disease (CKD) comprise...
Patients with end-stage kidney disease (ESKD) suffer from high levels of protein-bound uremic toxins...
Increasing incidence of renal pathology in the western world calls for innovative research for the d...
Novel renal replacement therapies, such as a bioartificial kidney (BAK), are needed to improve curre...
DMPK (Drug Metabolism and Pharmacokinetics) studies are essential for drug development but 90% of po...